---
figid: PMC6736176__radiol.2019190115.fig4
figtitle: Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular
  Carcinoma after Laser Thermal Ablation in Small-Animal Model
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6736176
filename: radiol.2019190115.fig4.jpg
figlink: pmc/articles/PMC6736176/figure/fig4/
number: F4
caption: 'Proposed mechanism of increased hepatocellular carcinoma (HCC) cell killing
  and reduced postablation tumor growth with neoadjuvant phoshoinositide 3-kinase
  (PI3K)/mammalian target of rapamycin (mTOR)/protein kinase B (AKT) pathway inhibition
  in combination with moderate heat stress and thermal ablation. Top: Incomplete thermal
  ablation of HCC cells induces activation of PI3K/mTORC2-dependent activating phosphorylation
  of AKT at serine (Ser) 473 and threonine (Thr) 308, which promotes cell survival,
  growth, and proliferation mechanisms while inhibiting cell death mechanisms, thereby
  resulting in local tumor recurrence and progression. Bottom: Neoadjuvant dual PI3K/mTOR
  inhibitor BEZ235 prior to thermal ablation prevents thermal ablation–induced activation
  of AKT signaling, which promotes cell death mechanisms while preventing cell survival,
  growth, and proliferation mechanisms, thereby resulting in a reduction in local
  tumor recurrence and progression.'
papertitle: Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular
  Carcinoma after Laser Thermal Ablation in Small-Animal Model.
reftext: Danielle E. Jondal, et al. Radiology.  September 2019;292(3):752-759.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8160757
figid_alias: PMC6736176__F4
figtype: Figure
redirect_from: /figures/PMC6736176__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6736176__radiol.2019190115.fig4.html
  '@type': Dataset
  description: 'Proposed mechanism of increased hepatocellular carcinoma (HCC) cell
    killing and reduced postablation tumor growth with neoadjuvant phoshoinositide
    3-kinase (PI3K)/mammalian target of rapamycin (mTOR)/protein kinase B (AKT) pathway
    inhibition in combination with moderate heat stress and thermal ablation. Top:
    Incomplete thermal ablation of HCC cells induces activation of PI3K/mTORC2-dependent
    activating phosphorylation of AKT at serine (Ser) 473 and threonine (Thr) 308,
    which promotes cell survival, growth, and proliferation mechanisms while inhibiting
    cell death mechanisms, thereby resulting in local tumor recurrence and progression.
    Bottom: Neoadjuvant dual PI3K/mTOR inhibitor BEZ235 prior to thermal ablation
    prevents thermal ablation–induced activation of AKT signaling, which promotes
    cell death mechanisms while preventing cell survival, growth, and proliferation
    mechanisms, thereby resulting in a reduction in local tumor recurrence and progression.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Akt
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - Ser
  - BEZ235
---
